HOME >> BIOLOGY >> NEWS
New England lakes hold clues to lurking storms and floods

Is New England headed for troubled waters? Devastating storms and floods may be ready to wreak havoc, according to geologists at the University of Vermont (UVM). Periods of intense storminess have peaked in the North Atlantic region roughly every 3,000 years over a 13,000 year period, according to research that will appear in the Oct. 24 issue of the journal Nature. These patterns are consistent with those recorded in the Greenland ice sheet, which carries signals in its chemical and physical properties that reflect an upswing in storminess over the past 600 years.

The geologists' research couldn't be more timely. "The last big group of storms was you guessed it almost 3,000 years ago," says Paul Bierman, co-author of "Millennial-scale storminess variability in the northeastern United States during the Holocene epoch" and UVM professor of geology. With funding from the National Science Foundation, Bierman enlisted a team of students to collect and study core samples from 21 lakes in Vermont and New York's Adirondacks over four years. The regional storm and flood patterns they were able to establish are red flags to emergency planners, who rely on early detection to quickly evacuate people to higher ground when waters rise.

There was no time for warnings, preparations or escape 75 years ago, when record rainfall overflowed rivers and partially submerged several Vermont towns, killing 55 people and destroying $30 million in property. But geologist Anders Noren says the 1927 flood was merely a drop in the bucket compared to earlier and future hydrologic hassles. "If this cycle continues, the frequency and severity of intense rainstorms that can cause massive flooding should continue to increase for the next several hundred years," Noren says. The impact of human activity, especially the emission of atmospheric greenhouse gases, could speed up storm cycles, he says.

Noren, who is lead author of the Nature paper, joined Bierman's research te
'"/>

Contact: Lynda Majairan
lynda.majarian@uvm.edu
802-656-1107
University of Vermont
23-Oct-2002


Page: 1 2

Related biology news :

1. New England forests at greater risk from air pollution
2. Water study yields a few surprises for New England
3. Results of pivotal study for GlaxoSmithKlines Valtrex published in New England Journal of Medicine
4. Researchers show autoantibodies occur before lupus in New England Journal of Medicine
5. New book says Northwest salmon could face same fate as those in Northeast, England
6. Arsenic in New England wells more widespread than thought
7. Antegren (natalizumab) clinical study results published in New England Journal of Medicine
8. New England Journal of Medicine highlights survival benefit of new treatment for non-Hodgkins lymphoma
9. Predicting preterm birth still nearly impossible, study in New England Journal finds
10. URI biological oceanographer examines the relationship between the inshore and offshore New England squid fishery
11. New England Water Is Improving But Problems Remain, Says New USGS Report

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New England lakes hold clues lurking storms and floods

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: